News Financials About Visit Website Latest News Nephros to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 & 1x1 Meetings on Thursday, May 2, 2024 Nephros Announces Fourth Quarter and Fiscal Year 2023 Financial Results Mar. 7, 2024 4:15 PM ET Nephros Schedules Conference Call for Fourth Quarter and Fiscal Year 2023 Financial Results Feb. 29, 2024 4:30 PM ET Nephros Announces Results for Quarter Ended September 30, 2023 Nov. 8, 2023 4:15 PM ET More News Financials About Contact 2013435202 Visit Website Nephros Hires Judy Krandel as Chief Financial Officer Nov. 1, 2023 7:30 AM ET Nephros Schedules Third Quarter 2023 Financial Results Conference Call Oct. 25, 2023 7:30 AM ET Nephros Announces Results for Quarter Ended June 30, 2023 Aug. 9, 2023 4:15 PM ET Nephros Schedules Second Quarter 2023 Financial Results Conference Call Jul. 26, 2023 7:30 AM ET Nephros Announces Results for Quarter Ended March 31, 2023 May. 10, 2023 4:15 PM ET Nephros Announces CEO Retirement and Succession Plan May. 8, 2023 7:30 AM ET Nephros Schedules First Quarter 2023 Financial Results Conference Call Apr. 26, 2023 7:30 AM ET Nephros Announces Preliminary Results for First Quarter 2023 Apr. 4, 2023 7:30 AM ET Nephros Announces Fourth Quarter and Fiscal Year 2022 Financial Results Mar. 8, 2023 4:15 PM ET Nephros and Donastar Announce Strategic Partnership Mar. 1, 2023 4:30 PM ET Nephros Fourth Quarter and Fiscal Year 2022 Financial Results Conference Call Feb. 22, 2023 4:30 PM ET Nephros Announces Preliminary Results for Fourth Quarter and Fiscal Year 2022 Jan. 11, 2023 7:30 AM ET Nephros Announces Results for Quarter Ended September 30, 2022 Nov. 2, 2022 4:15 PM ET Nephros Third Quarter 2022 Financial Results Conference Call Oct. 19, 2022 7:30 AM ET Nephros Announces Agreement to Sell Pathogen Detection Systems Business and Preliminary Results for Quarter Ended September 30, 2022 Oct. 11, 2022 7:30 AM ET Nephros Partners with Donastar and Tractor Beverage Company to Supply and Service Nationwide Fast-Casual Restaurant Operation Sep. 28, 2022 7:30 AM ET Nephros Appoints Joe Harris to Its Board of Directors Sep. 8, 2022 4:00 PM ET Nephros Announces Results for Quarter Ended June 30, 2022 Aug. 10, 2022 4:15 PM ET Nephros Second Quarter 2022 Financial Results Conference Call Jul. 27, 2022 7:30 AM ET Nephros Announces Preliminary Results for Quarter Ended June 30, 2022 and Projects Positive Net Cash Flow in 12 Months Jul. 6, 2022 7:30 AM ET Nephros Receives FDA 510(k) Clearance for HDF Assist Module May. 17, 2022 7:30 AM ET Nephros Announces Results for Quarter Ended March 31, 2022 May. 4, 2022 4:15 PM ET Nephros First Quarter 2022 Financial Results Conference Call Apr. 27, 2022 7:30 AM ET Nephros Unveils New Branding and Website Apr. 26, 2022 7:30 AM ET Nephros to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group LLC and Hosted by M-Vest Mar. 21, 2022 7:30 AM ET Nephros Announces Fourth Quarter and Fiscal Year 2021 Financial Results Feb. 23, 2022 4:15 PM ET Nephros Fourth Quarter 2021 Financial Results Conference Call Feb. 9, 2022 7:30 AM ET Nephros Issues 2022 Shareholder Letter Jan. 13, 2022 7:30 AM ET Nephros Announces Preliminary Results for Fourth Quarter and Fiscal Year 2021 and Revenue Guidance for 2022 Jan. 11, 2022 7:30 AM ET Nephros to Present at the Benchmark Company 10th Annual One-on-One Discovery Conference Nov. 23, 2021 4:15 PM ET Nephros Announces Results for Quarter Ended September 30, 2021 Nov. 4, 2021 4:15 PM ET Nephros Announces Third Quarter 2021 Financial Results Conference Call Oct. 21, 2021 7:30 AM ET Nephros Announces Preliminary Results for Third Quarter of 2021 Oct. 8, 2021 7:30 AM ET Nephros to Present at the LD Micro Main Event Oct. 5, 2021 7:30 AM ET Nephros to Present at the Virtual MicroCap Leadership Summit Sep. 15, 2021 9:42 AM ET Nephros Appoints Wes Lobo to Chief Commercial Officer Sep. 1, 2021 7:30 AM ET Nephros Announces Results for Quarter Ended June 30, 2021 Aug. 5, 2021 4:15 PM ET Nephros Announces Acquisition of GenArraytion, Inc. Jul. 12, 2021 7:30 AM ET Nephros CEO Presenting at Access to Giving Virtual Investor Conference Jul. 9, 2021 4:22 PM ET Nephros Announces Preliminary Results for Second Quarter of 2021 Jul. 8, 2021 7:30 AM ET Nephros Announces Results for Quarter Ended March 31, 2021 May. 6, 2021 4:15 PM ET Nephros Announces First Quarter 2021 Financial Results Conference Call Apr. 26, 2021 7:30 AM ET Nephros Announces Preliminary Results for First Quarter of 2021 Apr. 5, 2021 7:30 AM ET Nephros to Participate in M-Vest LLC and Maxim Group LLC Inaugural Emerging Growth Virtual Conference Mar. 10, 2021 7:30 AM ET Nephros Reports 2020 Fourth Quarter and Full Year Financial Results Mar. 1, 2021 4:15 PM ET Nephros Announces Fourth Quarter and Full Year 2020 Financial Results Conference Call Feb. 22, 2021 7:30 AM ET Nephros Hires Wes Lobo as Chief Marketing Officer Feb. 18, 2021 7:30 AM ET Nephros Announces Preliminary Financial Results for Fourth Quarter and Fiscal Year 2020 Jan. 12, 2021 7:30 AM ET Update: Nephros Provides Year-End Technology Update, Including HDF Program Status Jan. 5, 2021 10:59 AM ET Nephros Provides Year-End Technology Update, Including HDF Program Status Jan. 4, 2021 7:30 AM ET Nephros to Present at Three November Investment Conferences Nov. 9, 2020 7:30 AM ET Nephros Appoints Dan D'Agostino as CFO and Reports Third Quarter Financial Results Nov. 5, 2020 4:39 PM ET Nephros Announces Third Quarter 2020 Financial Results Conference Call Oct. 29, 2020 7:30 AM ET Nephros Announces Pricing of $5 Million Registered Direct Offering of Common Stock Oct. 16, 2020 7:30 AM ET Nephros Announces Release of DialyPath, a qPCR-based, Real-time, On-site Endotoxin Assay for Dialysis Water Oct. 13, 2020 7:30 AM ET Nephros to Present at MicroCap Rodeo Best Ideas Bowl on October 13th at 11:30 AM ET Oct. 7, 2020 7:30 AM ET Nephros Announces Preliminary Third Quarter Revenues of $2.1 Million Oct. 6, 2020 7:30 AM ET Nephros Names Andy Astor President and Chief Executive Officer Aug. 14, 2020 7:30 AM ET Nephros Reports Second Quarter Financial Results Aug. 5, 2020 4:15 PM ET Nephros Announces Second Quarter 2020 Financial Results Conference Call Jul. 29, 2020 7:30 AM ET Potable Water in Buildings Unoccupied During COVID-19 Pandemic Contains Far More Bacteria than in Occupied Buildings; Legionella does not Predominate Jul. 22, 2020 7:30 AM ET Nephros to Present at Zooming with LD Jul. 13, 2020 7:30 AM ET Nephros Announces Preliminary Financial Results for Second Quarter 2020 Jul. 8, 2020 7:30 AM ET Nephros Set to Join Russell Microcap Index Jun. 18, 2020 7:30 AM ET Nephros to Present at the Virtual Summer Summit Jun. 2, 2020 7:30 AM ET Nephros, Inc. to Hold Virtual Annual Meeting of Stockholders May. 11, 2020 4:15 PM ET Nephros Reports First Quarter Financial Results May. 6, 2020 4:15 PM ET Nephros Announces First Quarter 2020 Financial Results Conference Call Apr. 29, 2020 7:30 AM ET Nephros Announces Preliminary Financial Results for First Quarter 2020 Apr. 2, 2020 7:30 AM ET Specialty Renal Products Announces Appointment of Tony Robinson as Vice President of Operations Mar. 25, 2020 7:30 AM ET Nephros to Present at the Sidoti Spring 2020 Investor Conference Mar. 10, 2020 7:30 AM ET Nephros Reports 2019 Fourth Quarter and Full Year Financial Results Feb. 27, 2020 4:05 PM ET Nephros Announces Fourth Quarter and Full Year 2019 Financial Results Conference Call Feb. 20, 2020 7:30 AM ET Nephros Announces Pricing of $7.5 Million Underwritten Offering of Common Stock Jan. 31, 2020 7:30 AM ET Nephros Announces Launch of PluraPath(TM), a Real-Time, Portable, Water Pathogen Detection System Jan. 9, 2020 7:30 AM ET Nephros Announces Preliminary Financial Results for Fourth Quarter and Fiscal Year 2019 Jan. 6, 2020 7:30 AM ET Nephros Reports Third Quarter Financial Results Nov. 6, 2019 7:30 AM ET Nephros Announces Third Quarter 2019 Financial Results Conference Call Oct. 31, 2019 7:30 AM ET Nephros, Inc. (Nasdaq: NEPH) to Ring The Nasdaq Stock Market Closing Bell Oct. 14, 2019 7:30 AM ET Nephros Announces Preliminary Financial Results for Third Quarter 2019 Oct. 7, 2019 7:30 AM ET Nephros Announces Presentations at Five Upcoming Investor Conferences Sep. 3, 2019 7:30 AM ET Nephros Announces Listing on Nasdaq Capital Market Aug. 13, 2019 7:30 AM ET Nephros Reports Second Quarter Financial Results Aug. 7, 2019 4:05 PM ET Update - Nephros Announces Second Quarter 2019 Financial Results Conference Call and Record Revenue of Over $1 Million in July Jul. 30, 2019 1:40 PM ET Nephros Announces Second Quarter 2019 Financial Results Conference Call and Record Revenue of Over $1 Million in July Jul. 30, 2019 7:30 AM ET Nephros Announces Temporary Ticker Symbol Following Reverse Stock Split Jul. 10, 2019 10:38 AM ET Nephros Announces Preliminary Financial Results for Second Quarter 2019 and Reverse Stock Split Jul. 9, 2019 4:05 PM ET Nephros Announces $2 Million Private Placement May. 16, 2019 7:30 AM ET Nephros Reports First Quarter Financial Results May. 8, 2019 4:05 PM ET Nephros Appoints Tom Gwydir to its Board of Directors May. 1, 2019 4:00 PM ET Nephros to Report First Quarter 2019 Financial Results on May 8, 2019 May. 1, 2019 7:30 AM ET Nephros to Present at Taglich Brothers 16th Annual Investment Conference on April 30, 2019 in New York City Apr. 24, 2019 7:30 AM ET Nephros Announces Preliminary Financial Results for First Quarter 2019 Apr. 8, 2019 7:30 AM ET Nephros to Present at the Spring Investor Summit on April 1st in New York City Mar. 29, 2019 7:45 AM ET Nephros Reports 2018 Fourth Quarter and Full Year Financial Results and Provides Corporate Update Mar. 12, 2019 7:45 AM ET Nephros to Report Fourth Quarter and Year End 2018 Financial Results on March 12th, 2019 Mar. 6, 2019 4:15 PM ET
Nephros to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 & 1x1 Meetings on Thursday, May 2, 2024
Nephros Schedules Conference Call for Fourth Quarter and Fiscal Year 2023 Financial Results Feb. 29, 2024 4:30 PM ET
Nephros Fourth Quarter and Fiscal Year 2022 Financial Results Conference Call Feb. 22, 2023 4:30 PM ET
Nephros Announces Preliminary Results for Fourth Quarter and Fiscal Year 2022 Jan. 11, 2023 7:30 AM ET
Nephros Announces Agreement to Sell Pathogen Detection Systems Business and Preliminary Results for Quarter Ended September 30, 2022 Oct. 11, 2022 7:30 AM ET
Nephros Partners with Donastar and Tractor Beverage Company to Supply and Service Nationwide Fast-Casual Restaurant Operation Sep. 28, 2022 7:30 AM ET
Nephros Announces Preliminary Results for Quarter Ended June 30, 2022 and Projects Positive Net Cash Flow in 12 Months Jul. 6, 2022 7:30 AM ET
Nephros to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group LLC and Hosted by M-Vest Mar. 21, 2022 7:30 AM ET
Nephros Announces Preliminary Results for Fourth Quarter and Fiscal Year 2021 and Revenue Guidance for 2022 Jan. 11, 2022 7:30 AM ET
Nephros to Present at the Benchmark Company 10th Annual One-on-One Discovery Conference Nov. 23, 2021 4:15 PM ET
Nephros to Participate in M-Vest LLC and Maxim Group LLC Inaugural Emerging Growth Virtual Conference Mar. 10, 2021 7:30 AM ET
Nephros Announces Fourth Quarter and Full Year 2020 Financial Results Conference Call Feb. 22, 2021 7:30 AM ET
Nephros Announces Preliminary Financial Results for Fourth Quarter and Fiscal Year 2020 Jan. 12, 2021 7:30 AM ET
Update: Nephros Provides Year-End Technology Update, Including HDF Program Status Jan. 5, 2021 10:59 AM ET
Nephros Appoints Dan D'Agostino as CFO and Reports Third Quarter Financial Results Nov. 5, 2020 4:39 PM ET
Nephros Announces Pricing of $5 Million Registered Direct Offering of Common Stock Oct. 16, 2020 7:30 AM ET
Nephros Announces Release of DialyPath, a qPCR-based, Real-time, On-site Endotoxin Assay for Dialysis Water Oct. 13, 2020 7:30 AM ET
Nephros to Present at MicroCap Rodeo Best Ideas Bowl on October 13th at 11:30 AM ET Oct. 7, 2020 7:30 AM ET
Potable Water in Buildings Unoccupied During COVID-19 Pandemic Contains Far More Bacteria than in Occupied Buildings; Legionella does not Predominate Jul. 22, 2020 7:30 AM ET
Specialty Renal Products Announces Appointment of Tony Robinson as Vice President of Operations Mar. 25, 2020 7:30 AM ET
Nephros Announces Fourth Quarter and Full Year 2019 Financial Results Conference Call Feb. 20, 2020 7:30 AM ET
Nephros Announces Pricing of $7.5 Million Underwritten Offering of Common Stock Jan. 31, 2020 7:30 AM ET
Nephros Announces Launch of PluraPath(TM), a Real-Time, Portable, Water Pathogen Detection System Jan. 9, 2020 7:30 AM ET
Nephros Announces Preliminary Financial Results for Fourth Quarter and Fiscal Year 2019 Jan. 6, 2020 7:30 AM ET
Update - Nephros Announces Second Quarter 2019 Financial Results Conference Call and Record Revenue of Over $1 Million in July Jul. 30, 2019 1:40 PM ET
Nephros Announces Second Quarter 2019 Financial Results Conference Call and Record Revenue of Over $1 Million in July Jul. 30, 2019 7:30 AM ET
Nephros Announces Preliminary Financial Results for Second Quarter 2019 and Reverse Stock Split Jul. 9, 2019 4:05 PM ET
Nephros to Present at Taglich Brothers 16th Annual Investment Conference on April 30, 2019 in New York City Apr. 24, 2019 7:30 AM ET
Nephros to Present at the Spring Investor Summit on April 1st in New York City Mar. 29, 2019 7:45 AM ET
Nephros Reports 2018 Fourth Quarter and Full Year Financial Results and Provides Corporate Update Mar. 12, 2019 7:45 AM ET
Nephros to Report Fourth Quarter and Year End 2018 Financial Results on March 12th, 2019 Mar. 6, 2019 4:15 PM ET
